The Setup:
Eli Lilly (
LLY) is capitalizing on a massive fundamental double-catalyst—including new broad Medicare coverage for its weight-loss drugs—to trigger an explosive move. The stock has carved out a massive Base-on-Base structure on the monthly chart. After a deliberate retail shakeout, it immediately recovered the 50-Day Moving Average, broke out, and cleanly retested the structural breakout level. It has now launched to new All-Time Highs on a 235% Relative Volume surge, displaying extreme relative strength as capital aggressively rotates out of tech and into defensive healthcare giants.
Tip: Use
ELIL for a 2x leveraged ETF.
Reasoning:
Eli Lilly (
LLY) is capitalizing on a massive fundamental double-catalyst—including new broad Medicare coverage for its weight-loss drugs—to trigger an explosive move. The stock has carved out a massive Base-on-Base structure on the monthly chart. After a deliberate retail shakeout, it immediately recovered the 50-Day Moving Average, broke out, and cleanly retested the structural breakout level. It has now launched to new All-Time Highs on a 235% Relative Volume surge, displaying extreme relative strength as capital aggressively rotates out of tech and into defensive healthcare giants.Tip: Use
ELIL for a 2x leveraged ETF.Reasoning:
- Stacked Base on Base Structure (5-month consolidation resting on a 15-month base)
- Retail Shakeout & 50MA Recovery (Cleared weak hands and regained institutional support)
- Structural Retest (Orderly pullback to confirm old resistance as new support)
- Breakout to All-Time Highs on 235% Rvol (Massive institutional volume footprint)
- Fundamental Double-Catalyst (European regulatory backing + Medicare GLP-1 expansion)
- Leverage Option: ELIL (2x ETF)
Get my trade ideas straight to your inbox.
👉 profitpunch.org
👉 profitpunch.org
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Get my trade ideas straight to your inbox.
👉 profitpunch.org
👉 profitpunch.org
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.